Website
Role of CVBF
Partner
Description
The Global Research in Paediatrics – GRiP Project aims to create a network among the main international paediatric centres – with over 1,000 structures involved in Europe, the U.S., Canada, Japan and other countries – in the form of a “Network of Excellence” meant to stimulate and facilitate the development and safe use of medicines for children. This goal is especially achieved through a training program addressed to all interested professionals (pharmacologists, clinicians, researchers, etc.) and through an integrated use of the existing research capacities, thus reducing the fragmentation and duplication of activities.
One of the main initiatives is the launching of an International Master’s program in Paediatric Clinical Pharmacology. Moreover, the GriP Consortium is involved in the review of the methodological bases for the conduction of clinical trials in paediatrics.
Funds
Seventh Framework Programme, European Commission
Budget
12.6 million euro
EU Contribution
10.0 million euro
Duration
2011-2015
Partners
(1) Azienda Ospedaliera di Padova (AOPD), Italy (Coordinator); (2) United States Department of Health and Human Services (NICHD-NIH), USA; (3) European Medicines Agency (EMA), UK; (4) Erasmus Universitair Medisch Centrum Rotterdam (EMC), The Netherlands; (5) The University of Liverpool (ULIV-MCRN), UK; (6) Ospedale Pediatrico Bambino Gesù (OPBG), Italy; (7) Institut National de la Sante et de la Recherche Medicale (INSERM), France; (8) National Center for Child Health and Development (NCCHD), Japan; (9) St George’s Hospital Medical School (SGUL), UK; (10) Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF-TEDDY), Italy; (11) Universiteit Leiden (UL), The Netherlands; (12) Academisch Medisch Centrum bij de Universiteit van Amsterdam (AMC), the Netherlands; (13) Fundacion Vasca de Innovacion e Investigacion Sanitarias (BIOEF), Spain; (14) Instytut Pomnik Centrum Zdrowia Dziecka (PCZD), Poland; (15) World Health Organization (WHO), Switzerland; (16) The School of Pharmacy, University Of London (SoP), UK; (17) Helsingin ja Uudenmaan Sairaanhoitopiirin Kuntayhtymä (HUS), Finland; (18) Brighton Collaboration Foundation (BF), Switzerland; (19) Fondazione Penta-for the Treatment and Care of Children With Hiv-Onlus (PENTA), Italy; (20) Vereniging Samenwerkende Ouder- En Patientenorganisaties (VSOP), The Netherlands; (21) The Hospital for Sick Children (SICKKIDS), Canada.